Drugs / LV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03174405 Background | Jul 2017 → Jul 2020 | colorectal cancer | AIO-Studien-gGmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03174405 ↗ |
| Route | Intravenous | “LV at a dose of 400 mg/m2 iv (day 1)” NCT03174405 ↗ |